BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1313271)

  • 1. Partial mapping of cyclic nucleotide sites and studies of regulatory mechanisms of phosphodiesterases using cyclic nucleotide analogues.
    Thomas MK; Francis SH; Beebe SJ; Gettys TW; Corbin JD
    Adv Second Messenger Phosphoprotein Res; 1992; 25():45-53. PubMed ID: 1313271
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
    Azhaeva EV; Severin ES
    Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes.
    Hoskins B; Luong HB
    Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):381-4. PubMed ID: 6272381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative kinetic study of bovine calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes utilizing cAMP, cGMP and their 2'-O-anthraniloyl-,2'-O-(N-methylanthraniloyl)-derivatives as substrates.
    Grewal J; Karuppiah N; Mutus B
    Biochem Int; 1989 Dec; 19(6):1287-95. PubMed ID: 2561449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phosphodiesterases of cyclic GMP].
    Wróblewska H; Gorczyca WA
    Postepy Hig Med Dosw; 2001; 55(5):611-27. PubMed ID: 11795198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
    Medvedeva MV
    Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic nucleotide changes in X-irradiated synchronized Tetrahymena.
    Charp PA; Whitson GL
    Radiat Res; 1978 May; 74(2):323-34. PubMed ID: 208095
    [No Abstract]   [Full Text] [Related]  

  • 8. The binding of cyclic nucleotide analogs to a purified cyclic GMP-stimulated phosphodiesterase from bovine adrenal tissue.
    Erneux C; Miot F; Van Haastert PJ; Jastorff B
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(5):463-72. PubMed ID: 2999203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
    Weishaar RE; Quade MM; Schenden JA; Evans DB
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A photoaffinity probe covalently modifies the catalytic site of the cGMP-binding cGMP-specific phosphodiesterase (PDE-5).
    Corbin JD; Beasley A; Turko IV; Haik TL; Mangum KA; Wells JN; Francis SH; Sekhar KR
    Cell Biochem Biophys; 1998; 29(1-2):145-57. PubMed ID: 9631243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrolysis of cyclic nucleotides by a purified cGMP-stimulated phosphodiesterase: structural requirements for hydrolysis.
    Braumann T; Erneux C; Petridis G; Stohrer WD; Jastorff B
    Biochim Biophys Acta; 1986 Jun; 871(2):199-206. PubMed ID: 3011099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drosophila cyclic nucleotide phosphodiesterases.
    Davis RL; Kauvar LM
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():393-402. PubMed ID: 6326533
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclic-GMP-regulated enzymes and their possible physiological functions.
    Walter U
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():249-58. PubMed ID: 6145321
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of specific forms of cyclic nucleotide phosphodiesterases in cultured cells.
    Manganiello VC; Yamamoto T; Elks M; Lin MC; Vaughan M
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():291-301. PubMed ID: 6326529
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclic nucleotide phosphodiesterases.
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():1-416. PubMed ID: 6326516
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclic nucleotide phosphodiesterase activity in patients with obstructive airways disease.
    Polson JB; Krzanowski JJ; Goldman AL; Szentivanyi A
    Allergol Immunopathol (Madr); 1982; 10(2):101-4. PubMed ID: 6125092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into cGMP action.
    Corbin JD; Thomas MK; Wolfe L; Shabb JB; Woodford TA; Francis SH
    Adv Second Messenger Phosphoprotein Res; 1990; 24():411-8. PubMed ID: 2169819
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of the cyclic GMP-binding activity and of a cyclic GMP-dependent cyclic GMP phosphodiesterase in Dictyostelium discoideum.
    van Haastert PJ; van Walsum H; van der Meer RC; Bulgakov R; Konijn TM
    Mol Cell Endocrinol; 1982 Feb; 25(2):171-82. PubMed ID: 6276250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase dysfunction, cyclic GMP accumulation, and visual cell degeneration in early-onset inherited blindness.
    Lolley RN; Lee RH
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():315-27. PubMed ID: 6145326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.